文献速递脑血管病

延长心电监测与隐源性脑缺血二级预防

Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia.
PubMed 文献 · Stroke · 2019-06-20

该研究综合4项研究共1102例隐源性缺血性卒中或短暂性脑缺血发作患者,比较延长心电监测(PCM)与常规心电监测。PCM组房颤检出率和抗凝启动率更高,复发性卒中及卒中/TIA风险更低,但证据为初步性。

要点

  • PCM可提高隐源性卒中/TIA患者的房颤检出率并促进抗凝启动。
  • PCM与随访期复发性卒中及卒中/TIA风险降低相关。
  • 现有证据为初步性,指南对PCM临床获益仍不确定。

核心结论

  • PCM可能对隐源性IS/TIA患者的二级卒中预防产生有利影响,表现为房颤检出和抗凝启动增加、卒中复发减少。
  • 作者强调该结果为初步证据,尚需进一步研究确认。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、SCOPUS、CENTRAL及会议论文集。
  • 纳入4项研究(2项随机临床试验和2项观察性研究),共1102例患者,平均年龄68岁,41%为女性。
  • 比较隐源性IS或TIA患者接受PCM与常规(非PCM)心电监测的卒中复发率。

主要发现

  • PCM组房颤检出率高于常规监测组(风险比=2.46;95%CI,1.61-3.76)。
  • PCM组抗凝启动率高于常规监测组(风险比=2.07;95%CI,1.36-3.17)。
  • PCM组复发性卒中风险低于常规监测组(风险比=0.45;95%CI,0.21-0.97)。
  • PCM组复发性卒中/TIA风险低于常规监测组(风险比=0.49;95%CI,0.30-0.81)。
  • 按研究类型分层后,随机临床试验与观察性研究中PCM与非PCM的房颤检出、抗凝启动及IS/TIA复发率相当,异质性I2<12%。

临床怎么用

  • 对隐源性IS/TIA患者可考虑延长心电监测以检出常规监测未发现的房颤并指导抗凝。
  • 临床决策需结合现行指南对PCM临床获益尚不确定的立场及患者个体情况。

局限性

  • 仅纳入4项研究,其中2项为观察性研究,证据确定性有限。
  • 作者称结果为初步证据,指南对PCM的临床获益仍不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Although prolonged cardiac rhythm monitoring (PCM) can reveal a substantial proportion of ischemic stroke (IS) patients with atrial fibrillation not detected by conventional short-term monitoring, current guidelines indicate an uncertain clinical benefit for PCM. We evaluated the impact of PCM on secondary stroke prevention using data from available to date randomized clinical trials and observational studies. Methods- We performed a comprehensive literature search in MEDLINE, SCOPUS, CENTRAL (Cochrane Central Register of Controlled Trial), and conference proceedings to identify studies reporting stroke recurrence rates in patients with history of cryptogenic IS or transient ischemic attack (TIA) receiving PCM compared with patients receiving conventional (non-PCM) cardiac monitoring. Results- We included 4 studies (2 randomized clinical trials and 2 observational studies), including a total of 1102 patients (mean age: 68 years, 41% women). We documented an increased incidence of atrial fibrillation detection (risk ratio=2.46; 95% CI, 1.61-3.76) and anticoagulant initiation (risk ratio=2.07; 95% CI, 1.36-3.17) and decreased risk of recurrent stroke (risk ratio=0.45; 95% CI, 0.21-0.97) and recurrent stroke/TIA (risk ratio=0.49; 95% CI, 0.30-0.81) during follow-up for IS/TIA patients who underwent PCM compared with IS/TIA patients receiving conventional cardiac monitoring. In the subgroup analysis, according to study type, atrial fibrillation detection, anticoagulant initiation, and IS/TIA recurrence rates were comparable between PCM and non-PCM in randomized clinical trials and observational studies. No evidence of heterogeneity (I2<12%) was documented across all the aforementioned subgroups. Conclusions- We provide preliminary evidence for a potential impact of PCM on secondary stroke prevention, as patients with cryptogenic IS/TIA undergoing PCM had higher rates of atrial fibrillation detection, anticoagulant initiation, and lower stroke recurrence.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tsivgoulis G, Katsanos AH, Mac Grory B, et al. Prolonged Cardiac Rhythm Monitoring and Secondary Stroke Prevention in Patients With Cryptogenic Cerebral Ischemia. Stroke. 2019. PMID: 31216964. doi:10.1161/STROKEAHA.119.025169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。